3rd Circ. Backs Dismissal Of Heart Medication Warning Claim
The Third Circuit held Monday that Zydus Pharmaceuticals USA Inc.'s off-label marketing of a generic heart medication could not be subject to failure to law claims stemming from New Jersey law,...To view the full article, register now.
Already a subscriber? Click here to view full article